Indirect Comparisons of the Efficacy of Subcutaneous Epcoritamab Vs Chemoimmunotherapy in Patients with Relapsed or Refractory Large B-Cell Lymphoma
- Resource Type
- Abstract
- Source
- In
Blood 15 November 2022 140 Supplement 1:10934-10935 - Subject
- Language
- ISSN
- 0006-4971